Log in to your Inderes Free account to see all free content on this page.

ProstaLund

Less than 1K followers

Overview

Investor consensus

All

Press releases

3rd party

ShowingAll content types

Regulatory press release10/24/2025, 5:30 AM

PROSTALUND AB (publ) - Interim report January-September 2025

Press release9/12/2025, 6:00 AM

ProstaLund enters collaboration agreement with the XEN Group for the market in the United Arab Emirates and Oman

Press release9/10/2025, 6:00 AM

ProstaLund enters collaboration agreement with Mayumana Healthcare for the Benelux market

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account

Stock market's most popular morning newsletter

Analyst comments and recommendations

Stock comparison tool

PREMIUM account

All company reports and content

Premium tools (e.g. insider transactions & stock screener)

Model portfolio

Regulatory press release8/21/2025, 5:30 AM

ProstaLund AB - Interim Report January-June 2025

Press release6/26/2025, 2:45 PM

First CoreTherm® Eagle treatments performed in Denmark

Press release6/17/2025, 8:00 AM

Second clinic in Sweden starts treatment with CoreTherm® Eagle

Regulatory press release5/30/2025, 5:30 AM

ProstaLund AB - Interim report January-March 2025

Press release5/20/2025, 1:50 PM

First patients treated with CoreTherm® Eagle

Press release5/14/2025, 8:45 AM

First treatments with CoreTherm® Eagle to be performed next week – Key milestone for ProstaLund

Press release2/24/2025, 2:00 PM

Correction: Use of the Schelin Catheter® prior to water vapor thermal therapy shown to be cost-effective

Press release2/24/2025, 8:05 AM

Use of the Schelin Catheter® prior to water vapor thermal therapy shown to be cost-effective

Regulatory press release2/20/2025, 6:30 AM

ProstaLund AB - Year-end report 2024

Press release2/14/2025, 2:45 PM

New study confirms the strong efficacy of CoreTherm® in patients with large prostates

Press release1/27/2025, 9:00 AM

Elderly men treated with CoreTherm® for benign prostatic hyperplasia have lower risk for a prostate cancer diagnosis later in life compared to men treated with TURP, according to a new Swedish register study

Press release12/10/2024, 8:00 AM

Additional study published confirming effectiveness of transurethral intraprostatic anaesthesia (TUIA) using our Schelin Catheter® during benign prostatic enlargement treatments

Third party research11/11/2024, 12:11 PM

ProstaLund: CoreTherm Eagle flygfärdig - VH Corp

* Tio CoreTherm Eagle-maskiner är tillverkade * Förbättrat patientflöde jämfört med första halvåret * Vi behåller vårt motiverade värde om 0,81 SEK per aktie ProstaLunds nettoomsättning i Q3 om 3,5 MSEK var klart lägre jämfört med samma period 2023. ...

Press release11/7/2024, 11:00 AM

The first ten CoreTherm® Eagle machines are manufactured

Regulatory press release11/7/2024, 6:30 AM

Interim report January-September 2024

Press release10/11/2024, 8:00 AM

Short-term results and long-term durability after CoreTherm® treatments presented at the Emirates International Urological Conference in Dubai, UAE

Press release10/4/2024, 11:00 AM

First published report of transurethral intraprostatic anaesthesia (TUIA) using the Schelin Catheter® in patients undergoing holmium laser enucleation of the prostate

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.